Celldex Therapeutics, Inc. (CLDX) Financials

CLDX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 782.3 million 67.8 million
March 31, 2026 511.3 million 55.0 million
Dec. 31, 2025 583.0 million 55.8 million
Sept. 30, 2025 648.4 million 50.1 million

CLDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -60.6 million 8.4 million
March 31, 2026 -67.2 million 8.5 million
Dec. 31, 2025 -64.9 million 8.9 million
Sept. 30, 2025 -49.1 million 8.8 million

CLDX Net Income

No data available :(

CLDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 717.6 million - 4.9 million
March 31, 2026 451.5 million 443000 1.5 million
Dec. 31, 2025 518.6 million - 2.3 million
Sept. 30, 2025 583.2 million - 2.6 million

CLDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 77.8 million
March 31, 2026 66.6 million
Dec. 31, 2025 66.5 million
Sept. 30, 2025 66.4 million

CLDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3.2 million 67.5 million 13.1 million -
March 31, 2026 1.6 million 73.0 million 11.4 million -
Dec. 31, 2025 993000 75.4 million 11.9 million -
Sept. 30, 2025 440000 62.9 million 10.7 million -

CLDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 22000 -
March 31, 2026 15000 854000
Dec. 31, 2025 75000 -
Sept. 30, 2025 - 62.9 million

CLDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CLDX

Price: $41.95

52 week price:
19.72
45.14

Earnings Per Share: -4.35 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 345800

Ebitda: -30.7 million

Market Capitalization: 3.5 billion

Links: